US medical technology group, Cook Medical, is expecting regulatory approval soon on a new device being developed in Limerick that will change the lives of millions of people around the world suffering from circulatory problems.The company is well in to a recruitment campaign that will see 200 new staff working on its new Zilver PTX drug-eluting stent, which is used for the treatment of blocked arteries in the leg, reports Businessworld.ie. Cook Medical is investing E25m in a manufacturing and services facility in Limerick that will create the 200 jobs over the next five years and is currently building a state-of-the-art Clean Room.
Cook already employs 480 staff here, having established a base in Limerick's National Technology Park in 1996 and plans for its Limerick facility to be its world centre for Zilver PTX
